Editorial (Thematic Issue: Privileged Scaffolds in Natural Products and Drug Discovery)

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 11, 2016-05 ,pp. : 1199-1199

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Privileged Scaffolds from a Diversified Chemical Library for&bgr;-Secretase Inhibition

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 8, 2005-12 ,pp. : 595-600

Bentham Science Publishers

Access to resources Recommend Favorite

Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 10, 2017-06 ,pp. : 869-901

Bentham Science Publishers

Access to resources Recommend Favorite

The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases

By Bongarzone Salvatore   Bolognesi Maria Laura  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 251-268

Informa Healthcare

Access to resources Recommend Favorite

Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry

By  

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1528-1548

Bentham Science Publishers

Access to resources Recommend Favorite